INSTRUCTIONS The ABCs of RSV
- To take the test online, go to our secure website at www.nursingcenter.com/ce/NP. View instructions for taking the test online there.
- If you prefer to submit your test by mail, record your answers in the test answer section of the CE enrollment form on page 27. You may make copies of the form.
- Each question has only one correct answer. There is no minimum passing score required.
- Complete the registration information and course evaluation. Mail the completed form and registration fee of $12.95 to: Lippincott Professional Development CE Group, 74 Brick Blvd., Bldg. 4, Suite 206, Brick, NJ 08723. We will mail your certificate in 4 to 6 weeks. For faster service, include a fax number and we will fax your certificate within 2 business days of receiving your enrollment form. You will receive your CE certificate of earned contact hours and an answer key to review your results.
- Registration deadline is September 4, 2020.
DISCOUNTS and CUSTOMER SERVICE
- Send two or more tests in any nursing journal published by Lippincott Williams & Wilkins together and deduct $0.95 from the price of each test.
- We also offer CE accounts for hospitals and other healthcare facilities on nursingcenter.com. Call 1-800-787-8985 for details.
Lippincott Professional Development will award 1.0 contact hour for this continuing nursing education activity.
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.0 contact hour. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia, Georgia, and Florida CE Broker #50-1223.
The ABCs of RSV
General Purpose: To provide information about RSV, its prevalence, diagnosis, treatment, and prevention. Learning Objectives/Outcomes: After completing this continuing-education activity, you will be able to: 1. Examine prevalence of RSV. 2. List symptoms of, diagnostic measures for, and complications of RSV. 3. Identify RSV treatment and prevention.
- At what age would a child be most likely to contract RSV?
- 7 months
- 14 months
- 21 months
- What percentage of children contract RSV by the time they are 2 years old?
- What percentage of children develop a lower respiratory tract infection during their first RSV exposure?
- Which statement about the incidence of RSV is accurate?
- Throughout most of the U.S., RSV onset is from October to late January.
- The highest incidences occur in October and November.
- In warmer climates, RSV has a later onset and shorter duration.
- Initial RSV presentation usually includes
- Subsequent RSV infections
- are less severe.
- are reliably predicted by risk scoring tools.
- do not occur due to developed immunity.
- Evaluation for bronchiolitis should include
- differential diagnosis.
- radiologic studies.
- Approximately what percentage of children hospitalized for bronchiolitis have a coinfection?
- Coinfection is usually caused by a
- Which of the following is recommended for administration by nebulizer for RSV?
- Approximately 30% of infants hospitalized with bronchiolitis require
- chest physical therapy.
- fluid replacement.
- Which of the following is recommended to address an oxygen saturation of 88%?
- oxygen via high-flow nasal cannula
- continuous pulse oximetry
- deep suctioning
- According to the AAP, the preferred method for cleansing hands when caring for a child with bronchiolitis is
- povidone-iodine solution.
- alcohol-based rub.
- Once infected with RSV, most patients are contagious for
- 24 to 48 hours.
- 3 to 8 days.
- 2 weeks.
- Which statement about palivizumab is accurate?
- It is used for treatment of RSV.
- It works by injection of specific antigens to stimulate an immune response.
- It may be helpful in preventing serious lower respiratory tract disease from RSV.
- For which patient is palivizumab most likely to be recommended?
- neonate requiring oxygen
- 9-month-old infant with cystic fibrosis
- 5-month-old without heart failure
- Palivizumab is administered in
- daily doses.
- weekly doses.
- monthly doses.
- Worsening respiratory symptoms and negative serology warrants
- consult with a pulmonary specialist.
- corticosteroid administration.
- medical imaging.